window.pageData = {"stock":{"_id":3000000026358,"name":"平安港股医疗优选股票型证券投资基金（QDII）","fundSecondLevel":"QDII","stockType":"fund","areaCode":"cn","market":"a","status":"normal","stockCode":"026358","tickerId":26358,"shortName":"平安港股医疗优选股票（QDII）C","currency":"CNY","exchange":"jj","masterFundFlag":null,"indexFundFlag":null,"activeFundFlag":null,"etfFundFlag":null,"lofFundFlag":null,"pensionTargetFlag":null,"feederFundFlag":null,"classificationFlag":null,"closedEnd":null,"inceptionDate":"2026-01-29T16:00:00.000Z","pinyin":"paggylyxgpxzqtzjj(qdii)","fundCollectionId":4000050640000,"fundCollection":{"exchange":"jjgs","stockType":"fund_collection","stockCode":"50640000","tickerId":50640000,"name":"平安基金管理有限公司"},"managers":[{"name":"周思聪","stockType":"fund_manager","stockCode":"8801381514","exchange":"fm","tickerId":261903140470},{"name":"张淼","stockType":"fund_manager","stockCode":"8801394991","exchange":"fm","tickerId":2613150030}],"hotMetrics":{"fpr":{"stockId":3000000026358,"type":"fpr","f_cagr_p_r_fs_ssc":585,"f_cagr_p_r_fs_ssrp":0.8304794520547946,"f_p_r_m1_ssc":586,"f_p_r_m1_ssrp":0.9367521367521368},"fp":{"stockId":3000000026358,"type":"fp","last_data_date":"2026-04-28T16:00:00.000Z","f_p_r_m1":-0.03043902439024404,"f_cagr_p_r_fs":-0.006001200240048132},"f_nlacan":{"stockId":3000000026358,"type":"f_nlacan","f_nv_d":"2026-04-28T16:00:00.000Z","f_nv":0.9938,"f_nv_cr":-0.00986350503138389},"f_as":{"stockId":3000000026358,"type":"f_as","f_tas":249401680.6788,"f_tas_d":"2026-03-30T16:00:00.000Z"}},"masterSlaveFunds":[{"_id":3000000026357,"__csrcFundId":16355,"stockCode":"026357","masterFundShortName":"平安港股医疗优选股票（QDII）","fundSecondLevel":"QDII","stockType":"fund","areaCode":"cn","market":"a","tickerId":26357,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"平安港股医疗优选股票（QDII）(026357)","lastUpdated":"2026-05-01T05:08:44.021Z","name":"平安港股医疗优选股票型证券投资基金（QDII）","pinyin":"paggylyxgpxzqtzjj(qdii)","fundCollectionId":4000050640000,"setUpAssetScale":383455372.34,"setUpDate":"2026-01-28T16:00:00.000Z","setUpShares":383455372.34,"inceptionDate":"2026-01-29T16:00:00.000Z"}],"shareholdings":[{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000009926,"holdings":524000,"marketCap":60239087,"netValueRatio":0.0946,"quarterlyChange":0.1522123893805305,"stock":{"stockType":"company","exchange":"hk","stockCode":"09926","tickerId":9926,"name":"康方生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000001530,"holdings":2821000,"marketCap":56391756,"netValueRatio":0.0885,"quarterlyChange":-0.06368899917286963,"stock":{"stockCode":"01530","exchange":"hk","stockType":"company","tickerId":1530,"name":"三生制药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":688796,"holdings":480605,"marketCap":44705877,"netValueRatio":0.0702,"quarterlyChange":0.7684410646387818,"stock":{"name":"百奥赛图","exchange":"sh","stockType":"company","stockCode":"688796","tickerId":688796}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000009995,"holdings":477500,"marketCap":40390106,"netValueRatio":0.0634,"quarterlyChange":0.33055555555555527,"stock":{"stockType":"company","exchange":"hk","stockCode":"09995","tickerId":9995,"name":"荣昌生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000006990,"holdings":76800,"marketCap":31192857,"netValueRatio":0.049,"quarterlyChange":0.17287098419173907,"stock":{"exchange":"hk","stockType":"company","stockCode":"06990","tickerId":6990,"name":"科伦博泰生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000001801,"holdings":416000,"marketCap":31184381,"netValueRatio":0.049,"quarterlyChange":0.11344262295081897,"stock":{"stockCode":"01801","exchange":"hk","stockType":"company","tickerId":1801,"name":"信达生物"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000006160,"holdings":170200,"marketCap":25787720,"netValueRatio":0.0405,"quarterlyChange":-0.04294478527607337,"stock":{"stockCode":"06160","exchange":"hk","stockType":"company","tickerId":6160,"name":"百济神州"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000003347,"holdings":619100,"marketCap":22652527,"netValueRatio":0.0356,"quarterlyChange":-0.025660279823018994,"stock":{"stockType":"company","exchange":"hk","stockCode":"03347","tickerId":3347,"name":"泰格医药"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000009606,"holdings":83900,"marketCap":21853453,"netValueRatio":0.0343,"quarterlyChange":-0.010731052984573997,"stock":{"exchange":"hk","stockType":"company","stockCode":"09606","tickerId":9606,"name":"映恩生物-B"}},{"date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","fundId":3000000026357,"stockId":1000000000002315,"holdings":431000,"marketCap":21063522,"netValueRatio":0.0331,"quarterlyChange":0.5679886685552415,"stock":{"exchange":"hk","stockType":"company","stockCode":"02315","tickerId":2315,"name":"百奥赛图-B"}}]},"list":[{"_id":"69df1aa16c2088540a3fc413","date":"2026-03-30T16:00:00.000Z","declarationDate":"2026-04-14T16:00:00.000Z","stockId":3000000026357,"sao":"2026年一季度国内经济相对平稳，消费温和修复，地产仍处调整阶段，新质生产力相关产业表现相对亮眼。海外方面，美国经济韧性较强、通胀黏性犹存，美联储降息节奏延后，高利率环境持续；欧元区与日本复苏偏弱，全球经济分化格局延续。流动性上，国内货币政策维持偏松基调，财政靠前发力，市场流动性合理充裕；海外美元偏强，新兴市场资金面承压。地缘政治风险显著抬升，中东局势紧张加剧能源价格波动，俄乌冲突及区域摩擦持续推升全球风险溢价。A股市场整体呈结构性震荡，成交维持高位，市场波动加大，主线清晰但轮动较快。　　医药行业方面，政策端迎来战略定位跃升，2026年政府工作报告将生物医药列为新兴支柱产业。这是政府工作报告中首次以支柱产业的定位提出发展生物医药产业，释放出推动产业加速升级的重要政策信号，医药产业的国家战略地位正在进一步提升。将生物医药明确定位为“新兴支柱产业”，意味着国家层面对该产业的战略重视程度进一步提升，也有望在政策、资本以及产业生态等多个层面形成更强的支持合力。出海方面，创新药出海爆发式增长，一季度对外授权交易总额超600亿美元，接近2025年全年一半，首付款超33亿美元，平均单笔首付1.84亿美元，创历史新高。业绩方面，随着2025年年报的发布，多家上市公司宣布盈利，上市公司业绩持续修复，行业盈利拐点确立。　　本报告期内，以子行业的景气度为投资的重要策略，在商业模式、竞争力和业绩的多维度比较中寻找具有估值性价比的优秀公司，重点布局了创新药方向。未来仍然看好以创新药、创新医疗器械、医药外包服务为代表的成长型的医药子行业。　　截至本报告期末平安港股医疗优选股票（QDII）A的基金份额净值1.0198元，本报告期基金份额净值增长率为1.98%，同期业绩比较基准收益率为-9.93%；截至本报告期末平安港股医疗优选股票（QDII）C的基金份额净值1.0188元，本报告期基金份额净值增长率为1.88%，同期业绩比较基准收益率为-9.93%。","lastUpdated":"2026-04-15T04:57:05.821Z","fund":{"_id":3000000026357,"__csrcFundId":16355,"stockCode":"026357","masterFundShortName":"平安港股医疗优选股票（QDII）","fundSecondLevel":"QDII","stockType":"fund","areaCode":"cn","market":"a","tickerId":26357,"currency":"CNY","masterFundFlag":1,"status":"normal","exchange":"jj","shortName":"平安港股医疗优选股票（QDII）(026357)","lastUpdated":"2026-05-01T05:08:44.021Z","name":"平安港股医疗优选股票型证券投资基金（QDII）","pinyin":"paggylyxgpxzqtzjj(qdii)","fundCollectionId":4000050640000,"setUpAssetScale":383455372.34,"setUpDate":"2026-01-28T16:00:00.000Z","setUpShares":383455372.34,"inceptionDate":"2026-01-29T16:00:00.000Z","managers":[{"stockCode":"8801381514","stockType":"fund_manager","exchange":"fm","tickerId":261903140470,"name":"周思聪"},{"stockCode":"8801394991","stockType":"fund_manager","exchange":"fm","tickerId":2613150030,"name":"张淼"}]},"announcement":{"linkText":"平安港股医疗优选股票型证券投资基金（QDII） 2026年第1季度报告","linkUrl":"http://eid.csrc.gov.cn/fund/disclose/instance_show_pdf_id.do?instanceid=1466688","linkType":"PDF","source":"csrc_pdf"}}]}